NO177591C - Analogifremgangsmåte for fremstilling av terapeutisk aktive, selektive adenosin-receptormidler - Google Patents

Analogifremgangsmåte for fremstilling av terapeutisk aktive, selektive adenosin-receptormidler

Info

Publication number
NO177591C
NO177591C NO911200A NO911200A NO177591C NO 177591 C NO177591 C NO 177591C NO 911200 A NO911200 A NO 911200A NO 911200 A NO911200 A NO 911200A NO 177591 C NO177591 C NO 177591C
Authority
NO
Norway
Prior art keywords
therapeutically active
adenosine receptor
analogous process
selective adenosine
receptor agents
Prior art date
Application number
NO911200A
Other languages
English (en)
Norwegian (no)
Other versions
NO911200D0 (no
NO177591B (no
NO911200L (no
Inventor
Norton Paul Peet
Nelson Lowell Lentz
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO911200D0 publication Critical patent/NO911200D0/no
Publication of NO911200L publication Critical patent/NO911200L/no
Publication of NO177591B publication Critical patent/NO177591B/no
Publication of NO177591C publication Critical patent/NO177591C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO911200A 1990-03-26 1991-03-25 Analogifremgangsmåte for fremstilling av terapeutisk aktive, selektive adenosin-receptormidler NO177591C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/499,111 US5047534A (en) 1990-03-26 1990-03-26 Selective adenosine receptor agents

Publications (4)

Publication Number Publication Date
NO911200D0 NO911200D0 (no) 1991-03-25
NO911200L NO911200L (no) 1991-09-27
NO177591B NO177591B (no) 1995-07-10
NO177591C true NO177591C (no) 1995-10-18

Family

ID=23983864

Family Applications (1)

Application Number Title Priority Date Filing Date
NO911200A NO177591C (no) 1990-03-26 1991-03-25 Analogifremgangsmåte for fremstilling av terapeutisk aktive, selektive adenosin-receptormidler

Country Status (22)

Country Link
US (1) US5047534A (de)
EP (1) EP0449175B1 (de)
JP (1) JP3181305B2 (de)
KR (1) KR100195368B1 (de)
CN (1) CN1032815C (de)
AR (1) AR247887A1 (de)
AT (1) ATE156130T1 (de)
AU (1) AU632914B2 (de)
CA (1) CA2038747C (de)
DE (1) DE69127010T2 (de)
DK (1) DK0449175T3 (de)
ES (1) ES2107431T3 (de)
FI (1) FI98461C (de)
GR (1) GR3025135T3 (de)
HU (1) HU208824B (de)
IE (1) IE910982A1 (de)
IL (1) IL97656A (de)
NO (1) NO177591C (de)
NZ (1) NZ237484A (de)
PH (1) PH27511A (de)
PT (1) PT97133B (de)
ZA (1) ZA912038B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208240A (en) * 1991-03-12 1993-05-04 Merrell Dow Pharmaceuticals Inc. 8-substituted purines as selective adenosine receptor agents
CA2116967C (en) * 1992-07-08 2003-08-19 Fumio Suzuki Antidepressants
CN1041418C (zh) * 1993-02-26 1998-12-30 默里尔多药物公司 用作腺苷a1受体拮抗剂的黄嘌呤衍生物
AU6781194A (en) * 1993-05-03 1994-11-21 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The 8-substituted 1,3,7-trialkyl-xanthine derivatives as a2-selective adenosine receptor antagonists
JPH08509977A (ja) * 1993-05-06 1996-10-22 メレルダウファーマスーティカルズ インコーポレイテッド 選択的アデノシン受容体剤としての８−置換キサンチン類
US5629298A (en) * 1995-03-13 1997-05-13 University Of Massachusetts Medical Center Adenosine as a positive inotrop in the compromised heart
GB9819382D0 (en) 1998-09-04 1998-10-28 Cerebrus Ltd Chemical compounds I
US6258794B1 (en) 1999-12-14 2001-07-10 The Mclean Hospital Corporation Treatment of mental conditions including depression
CN1787821A (zh) * 2003-06-10 2006-06-14 协和发酵工业株式会社 一种治疗焦虑症的方法
WO2007036491A1 (de) * 2005-09-30 2007-04-05 Basf Aktiengesellschaft Verfahren zur herstellung von alpha-substituierten carbonsäuren
US7592461B2 (en) * 2005-12-21 2009-09-22 Bristol-Myers Squibb Company Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1435916A (en) * 1972-05-11 1976-05-19 Beecham Group Ltd Pharmaceutical weight-reducing compositions
SE416810C (sv) * 1977-10-14 1982-07-19 Draco Ab Forfarande for framstellning av xantinderivat med antiallergisk aktivitet
JPS57198544A (en) * 1981-05-28 1982-12-06 Sony Corp Manufacture of magnetic recording medium
US4593095A (en) * 1983-02-18 1986-06-03 The Johns Hopkins University Xanthine derivatives
US4772607A (en) * 1986-05-20 1988-09-20 Warner-Lambert Company Dialkenyl derivatives of xanthine, pharmaceutical compositions and methods of use therefor
US4783530A (en) * 1986-11-13 1988-11-08 Marion Laboratories, Inc. 8-arylxanthines
DE8817122U1 (de) * 1988-12-22 1993-02-04 Boehringer Ingelheim Kg, 55218 Ingelheim Neue Xanthinderivate mit Adenosinantogenistischer Wirkung

Also Published As

Publication number Publication date
JPH04221384A (ja) 1992-08-11
FI911420A0 (fi) 1991-03-25
FI98461C (fi) 1997-06-25
CN1055181A (zh) 1991-10-09
KR910016752A (ko) 1991-11-05
HUT56570A (en) 1991-09-30
AR247887A1 (es) 1995-04-28
FI911420L (fi) 1991-09-27
IE910982A1 (en) 1991-10-09
GR3025135T3 (en) 1998-02-27
DE69127010T2 (de) 1997-11-13
IL97656A (en) 1996-06-18
HU208824B (en) 1994-01-28
DE69127010D1 (de) 1997-09-04
NO911200D0 (no) 1991-03-25
US5047534A (en) 1991-09-10
KR100195368B1 (ko) 1999-06-15
ATE156130T1 (de) 1997-08-15
AU632914B2 (en) 1993-01-14
CN1032815C (zh) 1996-09-18
JP3181305B2 (ja) 2001-07-03
FI98461B (fi) 1997-03-14
NZ237484A (en) 1993-10-26
PT97133A (pt) 1991-12-31
ES2107431T3 (es) 1997-12-01
EP0449175B1 (de) 1997-07-30
DK0449175T3 (da) 1998-02-23
NO177591B (no) 1995-07-10
NO911200L (no) 1991-09-27
PT97133B (pt) 1998-07-31
CA2038747C (en) 2002-05-28
EP0449175A2 (de) 1991-10-02
AU7353791A (en) 1991-10-03
PH27511A (en) 1993-08-18
IL97656A0 (en) 1992-06-21
ZA912038B (en) 1991-12-24
CA2038747A1 (en) 1991-09-27
EP0449175A3 (en) 1993-01-20

Similar Documents

Publication Publication Date Title
NO176759C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater
FI913446L (fi) Menetelmä valmistaa terapeuttisesti aktiivista 3-(2-substituoitu-3-okso-2,3-dihydropyridatsin-6-yyli)-2-fenyylipyratsolo/1,5-a/pyridiinejä
NO180749C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive benzimidazolsubstituerte derivater
FI890282L (fi) Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
ZA909141B (en) Therapeutically active chloro substituted benzimidazoles,processes for their preparation as well as their use
FI883050L (fi) Menetelmä terapeuttisesti aktiivisten pyranoindolitsinokinoliinijohdannaisten valmistamiseksi
FI870903L (fi) Menetelmä terapeuttisesti aktiivisten alfa-heterosykleillä substituoitujen tolunitriilien valmistamiseksi
NO179908C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, carbocykliske adenosinanaloger
FI885153L (fi) Menetelmä terapeuttisesti aktiivisten 2',3'-dideoksi-2'-fluorinukleosidien valmistamiseksi
FI930150L (fi) Menetelmä terapeuttisesti aktiivisten indolijohdannaisten valmistamiseksi
NO174959C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive N-aminobutyl-N-fenyl-arylamidderivater
NO178967C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridazin-derivater
FI880467A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
FI924642L (fi) Menetelmä terapeuttisesti aktiivisten 3-indolyylitioasetaattijohdannaisten valmistamiseksi
NO173784C (no) Anaslogifremgangsmaate for fremstilling av terapeutisk aktive tieno-tri-azolo-diazepinderivater
FI884660L (fi) Menetelmä terapeuttisesti aktiivisten 2,2-dimetyylikromeenijohdannaisten valmistamiseksi
FI916058A7 (fi) Menetelmä terapeuttisesti aktiivisten dihydrobentsofuraanikarboksamidien valmistamiseksi
NO175781C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive tetracykliske forbindelser
FI925260L (fi) Menetelmä terapeuttisesti käyttökelpoisten 6-amino-substituoitujen oktahydro-1,7,8-indolitsiinitriolijohdannaisten valmistamiseksi
DK0449175T3 (da) Selektive adenosinreceptormidler
NO174200C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-imino-6-polyfluoralkoksybenzotiazol-forbindelser
FI911701L (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-substituoitujen alkyyli-3-karboksikarbapeneemien valmistamiseksi
NO174668C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2,5,6,7 tetranor-4,8-inter-m-fenylen PGI2 derivater
NO176242C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 5-substituerte ornithinderivater
FI943778A7 (fi) Menetelmä 1,1-dikloori-1-fluorietaanin valmistamiseksi

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN SEPTEMBER 2003